Literature DB >> 24726108

Biological characteristics of pediatric renal cell carcinoma associated with Xp11.2 translocations/TFE3 gene fusions.

Hong Cheng Song1, Ning Sun2, Wei Ping Zhang1, LeJian He3, Libing Fu3, ChengRu Huang1.   

Abstract

PURPOSE: To investigate the clinical features of pediatric Xp11.2 translocation renal cell carcinoma (RCC).
METHODS: A retrospective review of 22 cases over 35 years.
RESULTS: Xp11.2 translocation RCCs were identified in 13 boys and 9 girls with a median age of 10.5 years (range: 2.5-16 years). RCC presented with hematuria in 17, abdominal mass in 1, abdominal masses with hematuria in 2, abdominal pain with hematuria in 1, and as an incidental finding in 1 patient. Ten patients were classified stage I, 10 were stage III, and two were stage IV. Of the 10 patients with stage I RCCs, 3 patients with tumor measuring less than 7 cm had nephron-sparing surgery (NSS) and 17 patients underwent simple nephrectomy. A 15-cm tumor was incompletely removed in one patient and another patient with a 25-cm × 18-cm × 15-cm tumor had gross residual. Of the 15 patients followed up between 6 months and 35 years, 13 were still living and 2 had died after surgery.
CONCLUSIONS: Xp11.2 translocation RCC is the predominant form of pediatric RCC, associated with advanced stage at presentation. Nephrectomy is the usual treatment for RCC but NSS is an option for patients with tumors measuring<7 cm. Patients with N+M0 maintained a favorable prognosis following surgery alone.
© 2014.

Entities:  

Keywords:  Children; Renal cell carcinoma; TFE3 gene; Xp11.2 translocation

Mesh:

Substances:

Year:  2013        PMID: 24726108     DOI: 10.1016/j.jpedsurg.2013.10.005

Source DB:  PubMed          Journal:  J Pediatr Surg        ISSN: 0022-3468            Impact factor:   2.545


  10 in total

1.  Pseudocapsule of renal cell carcinoma associated with Xp11.2 translocation/TFE3 gene fusion: a clue for tumor enucleation?

Authors:  Xiangming Cheng; Jian He; Weidong Gan; Xiangshan Fan; Jun Yang; Bin Zhu; Hongqian Guo
Journal:  Int J Clin Exp Pathol       Date:  2015-05-01

2.  Non-Wilms' renal tumors in children: experience with 139 cases treated at a single center.

Authors:  Yi Wei Fang; Hong Cheng Song; Ning Sun; Wei Ping Zhang
Journal:  BMC Urol       Date:  2022-06-22       Impact factor: 2.090

3.  Xp11.2 translocation renal cell carcinoma with TFE3 gene fusion: A case report.

Authors:  Xiang Pan; Jing Quan; Liwen Zhao; Wenhua Li; Benlin Wei; Shangqi Yang; Yongqing Lai
Journal:  Mol Clin Oncol       Date:  2017-11-13

4.  Xp11.2 translocation renal cell carcinomas in young adults.

Authors:  Linfeng Xu; Rong Yang; Weidong Gan; Xiancheng Chen; Xuefeng Qiu; Kai Fu; Jin Huang; Guancheng Zhu; Hongqian Guo
Journal:  BMC Urol       Date:  2015-07-01       Impact factor: 2.264

Review 5.  Clinical characteristics of XP11.2 translocation/TFE3 gene fusion renal cell carcinoma: a systematic review and meta-analysis of observational studies.

Authors:  Xiangming Cheng; Weidong Gan; Gutian Zhang; Xiaogong Li; Hongqian Guo
Journal:  BMC Urol       Date:  2016-07-11       Impact factor: 2.264

6.  Renal Cell Carcinoma Associated with Xp11.2 Translocation/TFE3 Gene Fusions: Clinical Features, Treatments and Prognosis.

Authors:  Ning Liu; Zhen Wang; Weidong Gan; Lei Xiong; Baolei Miao; Xiancheng Chen; Hongqian Guo; Dongmei Li
Journal:  PLoS One       Date:  2016-11-28       Impact factor: 3.240

7.  Surgical treatment for Xp11.2 translocation renal cell carcinoma with venous thrombus: A STROBE-compliant study.

Authors:  Liyuan Ge; Xiaojun Tian; Jing Ma; Guojiang Zhao; Yimeng Song; Shudong Zhang; Lulin Ma
Journal:  Medicine (Baltimore)       Date:  2019-09       Impact factor: 1.817

8.  An organoid biobank for childhood kidney cancers that captures disease and tissue heterogeneity.

Authors:  Camilla Calandrini; Frans Schutgens; Rurika Oka; Thanasis Margaritis; Tito Candelli; Luka Mathijsen; Carola Ammerlaan; Ravian L van Ineveld; Sepide Derakhshan; Sanne de Haan; Emmy Dolman; Philip Lijnzaad; Lars Custers; Harry Begthel; Hindrik H D Kerstens; Lindy L Visser; Maarten Rookmaaker; Marianne Verhaar; Godelieve A M Tytgat; Patrick Kemmeren; Ronald R de Krijger; Reem Al-Saadi; Kathy Pritchard-Jones; Marcel Kool; Anne C Rios; Marry M van den Heuvel-Eibrink; Jan J Molenaar; Ruben van Boxtel; Frank C P Holstege; Hans Clevers; Jarno Drost
Journal:  Nat Commun       Date:  2020-03-11       Impact factor: 14.919

9.  Gender difference analysis of Xp11.2 translocation renal cell carcinomas's attack rate: a meta-analysis and systematic review.

Authors:  Wenyuan Zhuang; Ning Liu; Hongqian Guo; Chunni Zhang; Weidong Gan
Journal:  BMC Urol       Date:  2020-08-26       Impact factor: 2.264

10.  Factors Associated with Survival From Xp11.2 Translocation Renal Cell Carcinoma Diagnosis-A Systematic Review and Pooled Analysis.

Authors:  Yuqing Wu; Saisai Chen; Minhao Zhang; Kuangzheng Liu; Jibo Jing; Kehao Pan; Lihua Zhang; Bin Xu; Xiaoming Lu; Ming Chen
Journal:  Pathol Oncol Res       Date:  2021-03-30       Impact factor: 3.201

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.